|
|
Bioinformatics.org
|
![[?]](https://www.bioinformatics.org/images/icons/info.png)
|
|
Research
|
Online databases
Online analysis tools
Online education tools
|
|
Development
|
|
|
Forums
|
News & Commentary
Jobs Forum
(Career Center)
|
|
|
News & Commentary - Message forums
|
         
|
 |
|
|
An article by Matthew Herper:
``Two of the scientists most instrumental in mapping the human genome, Craig Venter and Eric Lander, have often been portrayed as being at each other's throats.
[...]
``But despite their competitive streaks, there is one thing that the two men agree on: The gold rush to patent individual gene sequences will probably yield very little in the way of profits. And that is a good thing, because the development of life-saving medicine depends on genes being accessible to as many companies as possible.
```The natural tendency I have found in the business community is to block things, to keep things secret,' says Venter, `to try and tie up everything whether they understand it or not for commercial advantage. That's what drove the patent craze on genes.' Some of the earliest and biggest products in biotechnology were proteins derived directly from patented gene sequences, and these had been very valuable. For instance, Epogen, made by Amgen, was derived from a single gene sequence.''
Full story:
http://www.forbes.com/2002/06/26/0626targets.html
More from Forbes.com: `The DNA Of Capitalism'
http://www.forbes.com/2002/06/26/0626genome.html
|
|
Expanded view | Monitor forum | Save place
Start a new thread:
You have to be to post a reply.
|
|
![[University of Birmingham]](https://www.bioinformatics.org/images/ack_banners/Birmingham-728x90.gif)
![[Patsnap]](https://www.bioinformatics.org/images/ack_banners/Patsnap-728x90.png)